Marcus Gerhardt

Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then.

Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then.

Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then.

Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then.

Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then.